Feds open new GSK China bribery investigation
GlaxoSmithKline said in a securities filing Wednesday that the DOJ and SEC asked for information about third-party advisers the company hired in China during a corruption investigation there.
GSK said it is also responding to requests from the SFO for more information about the third parties.… Continue Reading